The relationship of endogenous cortisol to psychiatric disorder: A review

Canadian Journal of Psychiatry

Volumn 42, Issue 4, 1997, Pages 415-420

  Kiraly, Stephen J ^a,b   Ancill, Raymond J ^a,b   Dimitrova, Gergana ^a  

^a St Vincent's Hospital   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Depression; Geriatric psychiatry; Glucocorticoids; Hypercortisolemia; Psychosis; Stress; Treatment resistance

Indexed keywords

HYDROCORTISONE;

AGING; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HIPPOCAMPUS; HORMONE ACTION; HUMAN; HYPERCORTISOLISM; NEUROTOXICITY; ONSET AGE; PSYCHOSIS; REVIEW; STRESS;

EID: 0030877869     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379704200409     Document Type: Review

References (85)

1. Berthold AA. Transplantation der Hoden. Archiv Anatomisch Physiologisch Wissenschaft Medizin 1849;16:42-6.
2. Asher R. Myxoedematous madness. BMJ 1949;2:555-62.
3. Cushing H. Psychiatric disturbances associated with disorders of ductless glands. American Journal of Insanity 1913;69:965-90.
4. Cushing H. Basophil adenomas of the pituitary body and their clinical manifestations. Bulletin of the Johns Hopkins Hospital 1932;50:137-95.
5. McEwen BS, Davis PG, Parsons B, Pfaff WG. The brain as target for steroid hormone action. Annu Rev Neurosci 1979;2:65-112.
6. Svanborg MA. Aging, health and vitality: results from the Gothenburg longitudinal study [keynote address]. Canadian Association on Gerontology, 19th Annual Meeting; 1990 Oct 26.
7. Gnam W, Flint AJ. New onset rapid cycling bipolar disorder in an 87 year old woman. Can J Psychiatry 1993;38:324-6.
8. Young RC, Klerman GL. Mania in late life: focus on age at onset. Am J Psychiatry 1992;149:867-76.
9. Alexopoulos GS, Young RC, Meyers BS. Late onset depression. Psychiatr Clin North Am 1988;2:101-15.
10. Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing's syndrome: relationship to Cortisol and adreno-corticotrophic hormone levels. Arch Intern Med 1981;191:215-9.
11. Dubrovsky B. Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression. J Psychiatry Neurosci 1993;18:4-16.
12. Dubrovsky B. Adrenal steroids and the physiopathology of a subset of depressive disorders. Med Hypotheses 1991;36:300-5.
13. Gibbons JL. Cortisol secretion rate in depressive illness. Arch Gen Psychiatry 1964;10:572-5.
14. Gibbons JL. Plasma Cortisol in depressive illness. J Psychiatry Res 1962; 1:162-71.
15. Pearson-Murphy BE. Steroids and depression. J Steroid Biochem Mol Biol 1991;38:537-59.
16. Nemeroff CB. The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 1988;21:76-82.
17. Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, and others. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand 1992;85:270-4.
18. Persky H. Blood corticotropin and adrenal weight-maintenance factor levels of anxious patients and normal subjects. Psychosom Med 1959;21:379-86.
19. Born J, de Kloet ER, Wenz H, Kern W, Fehm HL. Gluco- and antiminaralocorticoid effects on human sleep: a role for central corticosteroid receptors. Am J Physiol 1991;260:E183-E188.
20. Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA, and others. Prednisone effects on neurochemistry and behavior. Arch Gen Psychiatry 1990;47:963-8.
21. Filipini D, Gijsbers K, Birmingham MK, Kraulis I, Dubrovsky B. Modulation by adrenal steroids of limbic function. J Steroid Biochem Mol Biol 1991;39:245-52.
22. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatry Res 1985;19:57-64.
23. Schatzberg AF, Rothschild AJ. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Ann N Y Acad Sci 1988;537:462-71.
24. Gifford S, Gunderson JG. Cushing's disease as a psychosomatic disorder: a selective review of the clinical and experimental literature and a report often cases. Perspect Biol Med 1970;Winter:169-221.
25. Reder AT, Thapar M, Jensen MA. A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology 1994;44:2289-94.
26. Sapolsky RM. Is this relevant to the human? In: Sapolsky RM, editor. Stress, the aging brain and the mechanism of neuron death. Boston: MIT; 1992. p 315-7.
27. Young EA, Kwak SP, Kottak J. Negative feedback regulation following administration of chronic exogenous corticosterone. J Neuroendocrinol 1995;7:37-45.
28. Cohen S. Cushing's syndrome: a psychiatric study of 29 patients. Br J Psychiatry 1980;136:120-4.
29. Cleghorn RA. Adrenal cortical insufficiency: psychological and neurological observations. Can Med Assoc J 1951;65:449-54.
30. McEwen BS. Glucocorticoid-biogenic amine interactions in relation to mood and behaviour. Biochem Pharmacol 1987;36:1755-63.
31. Abramovicz M. Drugs that cause psychiatric symptoms.The Medical Letter 1993;35:65-70.
32. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME. Glucocorticoid induced impairment of declarative memory performance in adult humans. J Neurosci 1994;14:2047-53.
33. McEwen BS. Steroid hormones are multifunctional messengers of the brain. Trends in Endocrinology and Metabolism 1991;2:62-7.
34. Sapolsky RM. Glucocorticoids endanger hippocampal neurons. In: Sapolsky RM, editor. Stress, the aging brain and the mechanism of neuron death. Boston: MIT; 1992. p 119-258.
35. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, and others. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 1994;28:336-48.
36. Papez JA. A proposed mechanism for emotion. Archives of Neurology and Psychiatry 1937:38:725-49.
37. Milner B. Disorders of learning and memory after temporal lobe lesions in man. Clin Neurosurg 1972;19:421-46.
38. Cohen NJ, Eichenbaum H. Memory, amnesia and the hippocampal system. Cambridge: MIT; 1994.
39. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci 1990;13:359-62.
40. Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAa receptor: mechanism of action and physiological significance. Prog Neurobiol 1992;38:379-95.
41. Starkman MN. Hippocampal formation volume, memory dysfunction and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32:756-65.
42. Heinz RE, Martinez J, Haenggelli A. Reversibility of cerebral atrophy in anorexia nervosa and Cushing's syndrome. J Comput Assist Tomogr 1977;1:410-4.
43. Momose KJ, Kjellberg RN, Kliman B. High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's disease. Radiology 1971; 99:341-8.
44. Bentson JR, Winter J, Wilson G. Steroids and apparent cerebral atrophy on computed tomography scans. Assist J Comput Tomogr 1978;2:16.
45. Jensen T, Genefke I, Hildebrandt N. Cerebral atrophy in young torture victims. N Engl J Med 1982;307:1341-2.
46. Thygesen P, Harmann K, Willanger R. Concentration camp survivors in Denmark; persecution, disease, disability, compensation. Dan Med Bull 1970;17:65-7.
47. Corkin S, Rosen T, Sullivan E, Clegg R. Penetrating head injury in young adulthood exacerbates cognitive decline in later years. J Neurosci 1989;9:3876-7.
48. Kraepelin E. Manic depressive insanity and paranoia. Barclay RM, translator. Edinburgh: E & S Livingstone; 1921.
49. Stern ES. The psychopathology of manic depressive disorder and involutional melancholia. Br J Med Psychol 1944;20:20-32.
50. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149:999-1010.
51. Linkowsky P, Mendleewicz J, Kerkhofs M, LeClercq R, Golstein J, Brasseur M, and others. 24-hour profile of adrenocorticotropin, cortisol and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 1987;65:141-8.
52. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, and others. Cognitive effects of corticosteroids. Am J Psychiatry 1990;147:1297-303.
53. Rubinow DR, Post RM, Savard R, Gold PW. Cortisol hypersecretion and cognitive impairment in depression. Arch Gen Psychiatry 1984;41:279-83.
54. Arana GW. Intravenous dexamethasone for symptoms of major depressive disorder. Am J Psychiatry 1991;148:1401-2.
55. Arana GW. Dexamethasone for the treatment of depression: a preliminary report. J Clin Psychiatry 1991;52:304-6.
56. Arana GW, Santos AB, Laraia MT, McLeod-Bryant S. Beale MD, Rames LJ. Dexamethasone for the treatment of depression; a randomized, placebo-controlled, double-blind trial. Am J Psychiatry 1995;152:265-7.
57. Beale MD, Arana GW. Dexamethasone treatment of major depression in patients with bipolar disorder. Am J Psychiatry 1995;152:959-60.
58. Turner WJ. Dexamethasone suppression test: problems and promise [editorial]. Biol Psychiatry 1982;17:1-2.
59. Jeffcoate WJ, Silverstone JT, Edwards CRW, Besser GM. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol. Q J Med 1979;48:465-72.
60. Semenkovich CF. Endocrine diseases. In: Woodley M, Whelan A, editors. Manual medical therapeutics. Boston: Little, Brown & Company; 1993. p 414-6.
61. Landfield PW, Eldridge JC. Evolving aspects of the glucocorticoid hypothesis of brain aging; hormonal modulation of neuronal calcium homeostatsis. Neurobiol Aging 1994;15:579-88.
62. Coleman P, Flood D. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 1987;8:521-40.
63. Landfield PW. Nathan Shock Memorial Lecture 1990: the role of glucocorticoids in brain aging and Alzheimer's disease: an integrative physiological hypothesis. Exp Gerontol 1994;29:3-11.
64. Reus VI. Hormonal mediation of the memory disorder in depression. Drug Development and Research 1984;4:489-500.
65. Greden J, Flegel P, Haskett R. Age effects in serial hypothalamic-adrenal-pituitary monitoring. Psychoneuroendocrinology 1986;11:195-203.
66. APA Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 1987;144:1253-68.
67. Feldman D. Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocr Rev 1986;7:409-20.
68. Angeli A, Frairia R. Ketoconazole therapy in Cushing's disease. Lancet 1985;1:821.
69. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 1987;317:812-8.
70. Sonino N, Boscaro M, Fava GA, Mantero F. Prolonged treatment of Cushing's disease with metyrapone and glutethimide. IRCS Med Sci 1986;14:485-6.
71. Pearson Murphy BE, Filipini D, Ghadirian AM. Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. J Psychiatry Neurosci 1993;18:209-13.
72. Kramlinger KG, Peterson GC, Watson PK, Leonard LL. Metyrapone for depression and delirium secondary to Cushing's syndrome. Psychosomatics 1985;26:67-71.
73. Ravaris CL, Sateia MJ, Beroza KW, Noordsy DL, Brinck-Johnsen T. Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman. Arch Gen Psychiatry 1988;45:966-7.
74. Pearson-Murphy BE, Dhar V, Ghadirian AM, Chouinard G, Keller R. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 1991;11:121-6.
75. Anand A, Malison R, McDougle CJ, Price LH. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report. Biol Psychiatry 1995;37:338-40.
76. Thakore JH, Dinan TG. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 1995;37:364-8.
77. Dallman MF. Regulation of adrenocortical function following stress. In: Brown MR, Koob GF, River C, editors. Stress: neurobiology and neuroendocrinology. New York: Marcel Dekker; 1991. p 173-92.
78. Weiss JM. The effects of coping on stress. Journal of Comparative and Physiological Psychology 1968;65:251-60.
79. Weinberg J, Levine S. Psychobiology of coping in animals: the effects of predictability. In: Levine S. Ursin H, editors. Coping and health. New York: Plenum; 1980. p 39-59.
80. Breier A, Albus M, Pickar D, Zahn TP, Wolkowitz OM, Paul SM. Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological function. Am J Psychiatry 1987;144:1419-25.
81. Voigt K, Ziegler M, Grunert-Fuchs M, Bickel U, Fehm-Wolfsdorf G. Hormonal responses to exhausting physical exercise: the role of predictability and controllability of the situation. Psychoneuroendocrinology 1990;15:173-84.
82. Gunnar MR. Reactivity of the hypothalamic-pituitary-adrenocortical system to stressors in normal infants and children. Pediatrics 1992;90(Suppl):491S-497S.
83. Sapolsky RM. Why zebras don't get ulcers. New York: WH Freeman and Company; 1994.
84. Abelson JL, Curtis JC. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels. Am J Psychiatry 1996;153:69-73.
85. Diagnostic Products Corporation. COAT-A-COUNT. DHEA-SO4. Product monograph. 1995;Dec 7:1.